REG - Futura Medical PLC - Block Listing Update <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

19/05/2016 16:35

RNS Number : 7879Y
Futura Medical PLC
19 May 2016

19 May 2016
Futura Medical plc
("Futura" or the "Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.
The table below provides further detail.
Name of company:
Futura Medical plc
Name of scheme:
Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")
Period of return:
From:
To:
24 November 2015
19 May 2016


Number and class of securities not issued under the scheme(s)
USOS:
EMI:
Total:
1,440,600
1,394,141
2,834,741
Number of securities issued under the scheme(s) during the period 
Number of securities lapsed under the scheme(s) during the period
USOS:
EMI:
 Nil
 Nil
USOS:
EMI:
 Nil
 (50,000)
Balance under the scheme(s) of securities not yet issued at the end of the period
USOS:
EMI:
Total:
 1,440,600
 1,344,141
 2,784,741
Number and class of securities originally admitted and the date of admission
USOS:

USOS Total:
 814,424 on 25 May 2011 and 1,202,280 on 8 October 2013
2,016,704
EMI:

EMI Total:
1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013
2,988,296
Total:
 5,005,000
Name of contact:
Derek Martin, Chief Financial Officer
Telephone number of contact:
+44 (0) 1483 685 670
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
Email to: james.barder@futuramedical.com
www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong / Tom Smale Corporate Finance 
Tel:+44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
  END
BLRGGUAPAUPQGAB